ARK Genomic Revolution ETF (ARKG) Stock Price Today
Aura AI Summary
Key Stats
- $2.22BMarket Cap
- 9,843,298Volume
- Sector/ThematicSector
- $56.8552W High
- $24.8252W Low
- 34 DaysTypical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track ARK Genomic Revolution ETF (ARKG) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ARK Genomic Revolution ETF has traded between a low of $24.82 and a high of $56.85, highlighting its annual price range. Buy and sell ARK Genomic Revolution ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Most Recent News
Kingfisher Mining raises $2.25M to boost Copper Blow copper-gold exploration near Broken Hill.
Kingfisher Mining secured $2.25 million through a share placement at a 5.6% premium to fund expanded drilling and exploration at its Copper Blow Project near Broken Hill. Recent drilling showed promising copper-gold grades, with significant untested ...

Disc Medicine to webcast APOLLO Phase 3 trial results of bitopertin for erythropoietic protoporphyria
Disc Medicine announced a webcast on October 19, 2026, to discuss topline results from its APOLLO Phase 3 trial of bitopertin, an investigational oral drug for erythropoietic protoporphyria (EPP). Bitopertin targets glycine transporter 1 to modulate ...

Actinogen Medical nears key Alzheimer's trial results with strong cash position of A$21.9M.
Actinogen Medical completed the main phase of its XanaMIA Phase 2b/3 Alzheimer's trial, with topline results expected in November. The trial tests Xanamem 10 mg daily in mild to moderate Alzheimer's patients, focusing on cognitive outcomes. The compa...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.